Logo of Biotheus Inc.
Biotheus Inc. | 普米斯生物技术

The Future of
Immuno-oncology

We are a biotech startup focusing on the discovery and development of next generation antibody-based therapeutics.

Founded in April 2018, our senior management team has a wealth of experience in the US, UK and China, in the development of antibody therapeutics that have reached commercialization. These include Yervoy, Nulojix, Orencia, Humira, Tyvyt, and Trobalt. By March 2019, a total of $35 million was raised to fund our expanding therapeutics pipeline and bring products closer to the clinic.

Our HQ is located in Zhuhai, China, with R&D capabilities including antibody discovery, process development and analytical assessment platforms, including a pilot plant that would facilitate IND-enabling activities.

We also have R&D labs at Suzhou and Hong Kong Science & Technology Park (HKSTP) to study the mechanisms of Treg cells and innate immunity in cancer.

Pipeline

Program
Partner
Structure
Antibody Generation
Antibody Engineering
CMC/IND
Program
PM8001
Structure
biAB
Antibody Generation
Antibody Engineering
CMC/IND
Program
PM8003
Structure
triAB
Antibody Generation
Antibody Engineering
CMC/IND
Program
PM1003
Structure
biAB
Antibody Generation
Antibody Engineering
CMC/IND
Program
PM1008
Logo of Adimab LLC
Structure
biAB
Antibody Generation
Antibody Engineering
CMC/IND
Program
PM1011
Logo of Genbase Biotechnology Co., Ltd
Structure
mAB
Antibody Generation
Antibody Engineering
CMC/IND

Meet the Team

Contact Us

Zhuhai HQ

10B, Building 4, No 1 Keji 7th Road
Xiang Zhou District
Tangjiawan Town
Zhuhai City
Guangdong Province
519080
China
Tel: +86 756 6998555

Fax: +86 756 6998701

Email: info@biotheus.com

Suzhou

3/F Room 309, Block D
398 Ruoshui Road
Suzhou
Jiangsu Province
215123
China

Hong Kong

Unit 505 Biotech Centre 1
Hong Kong Science & Technology Park
9 Science Park West Avenue
Sha Tin
New Territories
Hong Kong